Stay updated on GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial
Sign up to get notified when there's something new on the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page.

Latest updates to the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNo significant changes to core study information were observed; the updates appear to be minor UI/layout adjustments that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedCore content updated to reflect operating-status notice and v3.2.0 release; prior v3.0.2 reference removed.SummaryDifference4%

- Check43 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, with no other content changes.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved key drug-safety topics (MedlinePlus sections on Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, and Substandard Drugs), significantly changing the page’s focus away from those topics.SummaryDifference0.5%

- Check58 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing the previous v3.0.1. The Back to Top link has been removed, with no changes to core content, pricing, or time-sensitive information.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

Stay in the know with updates to GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page.